JC polyoma viruria associates with protection from chronic kidney disease independently from apolipoprotein L1 genotype in African Americans
暂无分享,去创建一个
C. Langefeld | K. Skorecki | J. Divers | B. Freedman | P. Skewes-Cox | A. Hemal | P. Hicks | D. Ganem | D. Lyles | A. Kistler | Lijun Ma | J. Snipes | M. Murea | M. Spainhour | Johanna R. Abend | Jolyn Turner | Lihong Zhao | Peter Skewes-Cox
[1] K. Skorecki,et al. APOL1 risk variants enhance podocyte necrosis through compromising lysosomal membrane permeability. , 2014, American journal of physiology. Renal physiology.
[2] M. M. Teixeira,et al. Inflamação na doença renal crônica: papel de citocinas , 2011 .
[3] S. Rosset,et al. Missense mutations in the APOL1 gene are highly associated with end stage kidney disease risk previously attributed to the MYH9 gene , 2010, Human Genetics.
[4] John D Reveille,et al. End‐Stage Renal Disease in African Americans With Lupus Nephritis Is Associated With APOL1 , 2014, Arthritis & rheumatology.
[5] K. Lai,et al. Viral nephropathy , 2006, Nature Clinical Practice Nephrology.
[6] E. Auvinen,et al. A Case of Primary JC Polyomavirus Infection–Associated Nephropathy , 2014, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[7] R. Munivenkatappa,et al. Polyomavirus BK Versus JC Replication and Nephropathy in Renal Transplant Recipients: A Prospective Evaluation , 2007, Transplantation.
[8] 邹古明,et al. Viral nephropathy , 2010 .
[9] D. Brennan,et al. JC polyoma virus and kidney disease. , 2014, Kidney international.
[10] K. Skorecki,et al. Impact of APOL1 polymorphism and IL-1β priming in the entry and persistence of HIV-1 in human podocytes , 2016, Retrovirology.
[11] A. Ashley-Koch,et al. MYH9 and APOL1 are both associated with sickle cell disease nephropathy , 2011, British journal of haematology.
[12] K. Skorecki,et al. APOL1 nephropathy: from gene to mechanisms of kidney injury. , 2016, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[13] M. Ramsay,et al. APOL1 Risk Variants Are Strongly Associated with HIV-Associated Nephropathy in Black South Africans. , 2015, Journal of the American Society of Nephrology : JASN.
[14] H. Anders,et al. Renal microenvironments and macrophage phenotypes determine progression or resolution of renal inflammation and fibrosis. , 2011, Kidney international.
[15] T. Yoshikawa,et al. Multiplex Real-Time PCR Assay for Simultaneous Quantification of BK Polyomavirus, JC Polyomavirus, and Adenovirus DNA , 2010, Journal of Clinical Microbiology.
[16] C. Nast,et al. Collapsing glomerulopathy in a young woman with APOL1 risk alleles following acute parvovirus B19 infection: a case report investigation , 2016, BMC Nephrology.
[17] A. Tenório,et al. Prevalence and patterns of polyomavirus urinary excretion in immunocompetent adults and children. , 2004, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[18] B. Freedman,et al. Localization of APOL1 protein and mRNA in the human kidney: nondiseased tissue, primary cells, and immortalized cell lines. , 2015, Journal of the American Society of Nephrology : JASN.
[19] V. D’Agati,et al. Innate immunity pathways regulate the nephropathy gene Apolipoprotein L1 , 2014, Kidney international.
[20] Richard D Moore,et al. Risk factors for chronic kidney disease in a large cohort of HIV-1 infected individuals initiating antiretroviral therapy in routine care , 2012, AIDS.
[21] C. Winkler,et al. Association of Trypanolytic ApoL1 Variants with Kidney Disease in African Americans , 2010, Science.
[22] Mahmud Tareq Hassan Khan,et al. BK virus‐associated infection in cerebrospinal fluid of neurological patients and mutation analysis of the complete VP1 gene in different patient groups , 2012, Journal of cellular physiology.
[23] C. Nast,et al. HIV-associated nephropathy. A unique combined glomerular, tubular, and interstitial lesion. , 1988, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.
[24] T. Naidich,et al. BK virus encephalopathy and sclerosing vasculopathy in a patient with hypohidrotic ectodermal dysplasia and immunodeficiency , 2016, Acta Neuropathologica Communications.
[25] S. Lacey,et al. A comparative study of Merkel cell, BK and JC polyomavirus infections in renal transplant recipients and healthy subjects. , 2010, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.
[26] Giulio Genovese,et al. APOL1 genetic variants in focal segmental glomerulosclerosis and HIV-associated nephropathy. , 2011, Journal of the American Society of Nephrology : JASN.
[27] J. Kopp. JC viruria and kidney disease in APOL1 risk genotype individuals: is this a clue to a gene × environment interaction? , 2013, Kidney international.
[28] E. Major,et al. Inhibitory interactions between BK and JC virus among kidney transplant recipients. , 2011, Journal of the American Society of Nephrology : JASN.
[29] A. Vallinoto,et al. Prevalence of infection by JC and BK polyomaviruses in kidney transplant recipients and patients with chronic renal disease , 2011, Transplant infectious disease : an official journal of the Transplantation Society.
[30] M. Rocco,et al. JC polyoma virus interacts with APOL1 in African Americans with non-diabetic nephropathy , 2013, Kidney international.
[31] B. Freedman,et al. Hypertension-attributed nephropathy: what's in a name? , 2016, Nature Reviews Nephrology.
[32] M. Rocco,et al. Association of APOL1 variants with mild kidney disease in first-degree relatives of African American patients with non-diabetic end stage renal disease , 2012, Kidney international.
[33] D. Fine,et al. APOL1 risk variants predict histopathology and progression to ESRD in HIV-related kidney disease. , 2012, Journal of the American Society of Nephrology : JASN.
[34] Nicholette D. Palmer,et al. APOL1 associations with nephropathy, atherosclerosis, and all-cause mortality in African Americans with type 2 diabetes , 2014, Kidney international.
[35] D. Whitby,et al. Viruses and kidney disease: beyond HIV. , 2008, Seminars in nephrology.
[36] M. Humphreys. Human immunodeficiency virus-associated glomerulosclerosis. , 1995, Kidney international.
[37] Adrian Egli,et al. Prevalence of polyomavirus BK and JC infection and replication in 400 healthy blood donors. , 2009, The Journal of infectious diseases.
[38] M. Teixeira,et al. [Inflammation in chronic kidney disease: the role of cytokines]. , 2011, Jornal brasileiro de nefrologia : 'orgao oficial de Sociedades Brasileira e Latino-Americana de Nefrologia.
[39] K. Stellrecht,et al. JC polyomavirus nephropathy, a rare cause of transplant dysfunction: Case report and review of literature , 2017, Transplant infectious disease : an official journal of the Transplantation Society.